Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer

Patricia L. Judson, Melissa A. Geller, Robin L. Bliss, Matthew P. Boente, Levi S. Downs, Peter A. Argenta, Linda F. Carson

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Objective. Studies in several solid tumors have shown that the presence of occult metastasis in the bone marrow or peripheral blood is highly predictive of decreased disease-free and overall survival. Our objective was to determine the incidence of circulating ovarian or primary peritoneal cancer cells in the peripheral blood at the time of disease diagnosis, or recurrence, and to determine the prognostic significance of these occult metastasis. Methods. Peripheral blood was drawn preoperatively from 91 women thought to have newly diagnosed or recurrent epithelial ovarian or primary peritoneal carcinoma. All samples underwent a tumor-enriched immunocytochemical assay. Results. Sixty-four women were found to have epithelial ovarian or primary peritoneal cancer. Of the 64 women with cancer, 12 had evidence of circulating cancer cells in their peripheral blood (18.7%). Characteristics were compared between those with circulating cancer cells and those without, using Fisher's exact test or the Wilcoxon-Mann-Whitney test, as appropriate. Women with circulating cancer cells had statistically more grade 3 tumors than women without. At a mean follow-up of 18.7 months (SD 6.7 months), analysis using Kaplan-Meier estimation and the log-rank test indicated that survival curves did not differ between patients with and without circulating cancer cells. Conclusion. Ovarian and primary peritoneal cancer, which historically has been thought to spread primarily by direct cell seeding throughout the abdominal cavity, can have circulating cancer cells in the peripheral blood. The clinical utility of identifying circulating cancer cells is yet to be defined.

Original languageEnglish (US)
Pages (from-to)389-394
Number of pages6
JournalGynecologic oncology
Volume91
Issue number2
DOIs
StatePublished - Nov 2003

Fingerprint

Ovarian Neoplasms
Neoplasms
Neoplasm Metastasis
Abdominal Cavity
Kaplan-Meier Estimate
Disease-Free Survival
Bone Marrow
Carcinoma
Recurrence

Cite this

Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer. / Judson, Patricia L.; Geller, Melissa A.; Bliss, Robin L.; Boente, Matthew P.; Downs, Levi S.; Argenta, Peter A.; Carson, Linda F.

In: Gynecologic oncology, Vol. 91, No. 2, 11.2003, p. 389-394.

Research output: Contribution to journalArticle

Judson, Patricia L. ; Geller, Melissa A. ; Bliss, Robin L. ; Boente, Matthew P. ; Downs, Levi S. ; Argenta, Peter A. ; Carson, Linda F. / Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer. In: Gynecologic oncology. 2003 ; Vol. 91, No. 2. pp. 389-394.
@article{950194d46f1c4664aa2a1b788b8d2720,
title = "Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer",
abstract = "Objective. Studies in several solid tumors have shown that the presence of occult metastasis in the bone marrow or peripheral blood is highly predictive of decreased disease-free and overall survival. Our objective was to determine the incidence of circulating ovarian or primary peritoneal cancer cells in the peripheral blood at the time of disease diagnosis, or recurrence, and to determine the prognostic significance of these occult metastasis. Methods. Peripheral blood was drawn preoperatively from 91 women thought to have newly diagnosed or recurrent epithelial ovarian or primary peritoneal carcinoma. All samples underwent a tumor-enriched immunocytochemical assay. Results. Sixty-four women were found to have epithelial ovarian or primary peritoneal cancer. Of the 64 women with cancer, 12 had evidence of circulating cancer cells in their peripheral blood (18.7{\%}). Characteristics were compared between those with circulating cancer cells and those without, using Fisher's exact test or the Wilcoxon-Mann-Whitney test, as appropriate. Women with circulating cancer cells had statistically more grade 3 tumors than women without. At a mean follow-up of 18.7 months (SD 6.7 months), analysis using Kaplan-Meier estimation and the log-rank test indicated that survival curves did not differ between patients with and without circulating cancer cells. Conclusion. Ovarian and primary peritoneal cancer, which historically has been thought to spread primarily by direct cell seeding throughout the abdominal cavity, can have circulating cancer cells in the peripheral blood. The clinical utility of identifying circulating cancer cells is yet to be defined.",
author = "Judson, {Patricia L.} and Geller, {Melissa A.} and Bliss, {Robin L.} and Boente, {Matthew P.} and Downs, {Levi S.} and Argenta, {Peter A.} and Carson, {Linda F.}",
year = "2003",
month = "11",
doi = "10.1016/j.ygyno.2003.08.004",
language = "English (US)",
volume = "91",
pages = "389--394",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer

AU - Judson, Patricia L.

AU - Geller, Melissa A.

AU - Bliss, Robin L.

AU - Boente, Matthew P.

AU - Downs, Levi S.

AU - Argenta, Peter A.

AU - Carson, Linda F.

PY - 2003/11

Y1 - 2003/11

N2 - Objective. Studies in several solid tumors have shown that the presence of occult metastasis in the bone marrow or peripheral blood is highly predictive of decreased disease-free and overall survival. Our objective was to determine the incidence of circulating ovarian or primary peritoneal cancer cells in the peripheral blood at the time of disease diagnosis, or recurrence, and to determine the prognostic significance of these occult metastasis. Methods. Peripheral blood was drawn preoperatively from 91 women thought to have newly diagnosed or recurrent epithelial ovarian or primary peritoneal carcinoma. All samples underwent a tumor-enriched immunocytochemical assay. Results. Sixty-four women were found to have epithelial ovarian or primary peritoneal cancer. Of the 64 women with cancer, 12 had evidence of circulating cancer cells in their peripheral blood (18.7%). Characteristics were compared between those with circulating cancer cells and those without, using Fisher's exact test or the Wilcoxon-Mann-Whitney test, as appropriate. Women with circulating cancer cells had statistically more grade 3 tumors than women without. At a mean follow-up of 18.7 months (SD 6.7 months), analysis using Kaplan-Meier estimation and the log-rank test indicated that survival curves did not differ between patients with and without circulating cancer cells. Conclusion. Ovarian and primary peritoneal cancer, which historically has been thought to spread primarily by direct cell seeding throughout the abdominal cavity, can have circulating cancer cells in the peripheral blood. The clinical utility of identifying circulating cancer cells is yet to be defined.

AB - Objective. Studies in several solid tumors have shown that the presence of occult metastasis in the bone marrow or peripheral blood is highly predictive of decreased disease-free and overall survival. Our objective was to determine the incidence of circulating ovarian or primary peritoneal cancer cells in the peripheral blood at the time of disease diagnosis, or recurrence, and to determine the prognostic significance of these occult metastasis. Methods. Peripheral blood was drawn preoperatively from 91 women thought to have newly diagnosed or recurrent epithelial ovarian or primary peritoneal carcinoma. All samples underwent a tumor-enriched immunocytochemical assay. Results. Sixty-four women were found to have epithelial ovarian or primary peritoneal cancer. Of the 64 women with cancer, 12 had evidence of circulating cancer cells in their peripheral blood (18.7%). Characteristics were compared between those with circulating cancer cells and those without, using Fisher's exact test or the Wilcoxon-Mann-Whitney test, as appropriate. Women with circulating cancer cells had statistically more grade 3 tumors than women without. At a mean follow-up of 18.7 months (SD 6.7 months), analysis using Kaplan-Meier estimation and the log-rank test indicated that survival curves did not differ between patients with and without circulating cancer cells. Conclusion. Ovarian and primary peritoneal cancer, which historically has been thought to spread primarily by direct cell seeding throughout the abdominal cavity, can have circulating cancer cells in the peripheral blood. The clinical utility of identifying circulating cancer cells is yet to be defined.

UR - http://www.scopus.com/inward/record.url?scp=0242352423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242352423&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2003.08.004

DO - 10.1016/j.ygyno.2003.08.004

M3 - Article

C2 - 14599871

AN - SCOPUS:0242352423

VL - 91

SP - 389

EP - 394

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -